Research Research Areas Research Groups Selected Publications Selected Projects Open Science
Laboratories Core Facilities Booking system Industry 4.0 Testbed Industry Cooperation
Education PhD School Postdoc Programme Seminar Series CEITEC Student Talent Internships
Career Training Jobs HRS4R Award Alumni Network Welcome Office Innovation Accelerator
About Us News Events People Organisational Structure Scientific Evaluation To Download Press and Media Contacts
CZ
Home Research Selected Publications Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial Research Research Areas Medical Genomics
Share Share Share

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial

JOURNAL OF CLINICAL ONCOLOGY

Cortes, JE; Saglio, G; Kantarjian, HM; Baccarani, M; Mayer, J; Boque, C; Shah, NP; Chuah, C; Casanova, L; Bradley-Garelik, B; Manos, G; Hochhaus, A, 2016: Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial. JOURNAL OF CLINICAL ONCOLOGY 34(20), p. 2333 - U54, doi: 10.1200/JCO.2015.64.8899

CEITEC authors: